BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 4164676)

  • 1. Studies on the metabolic error in Refsum's disease.
    Steinberg D; Mize CE; Avigan J; Fales HM; Eldjarn L; Try K; Stokke O; Refsum S
    J Clin Invest; 1967 Mar; 46(3):313-22. PubMed ID: 4164676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease.
    Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D
    J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refsum's disease: nature of the enzyme defect.
    Steinberg D; Herndon JH; Uhlendorf BW; Mize CE; Avigan J; Milne GW
    Science; 1967 Jun; 156(3783):1740-2. PubMed ID: 4180573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease.
    Baxter JH
    J Lipid Res; 1968 Sep; 9(5):636-41. PubMed ID: 4177872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease.
    Krauß S; Michaelis L; Vetter W
    PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol.
    Friedman KJ; Shapiro SS
    Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid composition of skin and plasma lipids in Refsum's disease.
    Reynolds DJ; Marks R; Davies MG; Dykes PJ
    Clin Chim Acta; 1978 Dec; 90(2):171-7. PubMed ID: 82497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange for Refsum's disease.
    Gibberd FB
    Transfus Sci; 1993 Jan; 14(1):23-6. PubMed ID: 10150979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phytol and phytanic acid in 2 cases of hereditary chronic polyneuropathy with uncertain classification: correlations with Refsum's disease].
    Livrea P
    Acta Neurol (Napoli); 1973; 28(1):47-59. PubMed ID: 4122245
    [No Abstract]   [Full Text] [Related]  

  • 13. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.
    Herndon JH; Steinberg D; Uhlendorf BW
    N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238
    [No Abstract]   [Full Text] [Related]  

  • 14. Elucidation of the metabolic error in Refsum's disease: strategy and tactics.
    Steinberg D
    Adv Neurol; 1978; 21():113-24. PubMed ID: 83783
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refsum's disease: characterization of the enzyme defect in cell culture.
    Herndon JH; Steinberg D; Uhlendorf BW; Fales HM
    J Clin Invest; 1969 Jun; 48(6):1017-32. PubMed ID: 4181593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease.
    Stokke O; Try K; Eldjarn L
    Biochim Biophys Acta; 1967 Oct; 144(2):271-84. PubMed ID: 4168936
    [No Abstract]   [Full Text] [Related]  

  • 18. Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.
    Steinberg D; Mize CE; Herndon JH; Fales HM; Engel WK; Vroom FQ
    Arch Intern Med; 1970 Jan; 125(1):75-87. PubMed ID: 4188898
    [No Abstract]   [Full Text] [Related]  

  • 19. Nutritional and metabolic aspects of heredopathia atactica polyneuritiformis (Refsum's syndrome).
    Lenk W
    Nutr Metab; 1974; 16(6):366-74. PubMed ID: 4135766
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK; Dyck PJ
    Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.